Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

International Journal of Radiation Oncology, Biology, Physics, Volume 97, Issue 2, 2017 Feb 1 | Narayan, Vivek, MD; Vapiwala, Neha, MD; Mick, Rosemarie, MS;...
Summary The mammalian target of rapamycin signaling pathway is implicated in prostate cancer progression and in the development of resistance to therapeutic ionizing radiation. We conducted a phase 1 clinical trial to evaluate everolimus in combin...

http://ift.tt/2iTN7Gg